Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension
NCT00185315
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
71
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension, Pulmonary
Interventions
DRUG:
Ventavis (Iloprost, BAYQ6256)
Sponsor
Bayer